πŸ‡ΊπŸ‡Έ FDA
Patent

US 8383589

Aegyptin and uses thereof

granted A61KA61K38/00A61K38/49

Quick answer

US patent 8383589 (Aegyptin and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K38/49, A61K39/0003, A61K45/06